Simon J. Baumgart
发表
G. Sauter,
R. Simon,
H. Huland,
2021,
Cancer gene therapy.
B. Haendler,
Simon J. Baumgart,
2017,
International journal of molecular sciences.
M. Nyberg,
G. Borghetti,
Simon J. Baumgart,
2022,
Cells.
E. Nevedomskaya,
Hannes Hahne,
B. Haendler,
2022,
Cancers.
E. Nevedomskaya,
B. Haendler,
Simon J. Baumgart,
2019,
International journal of molecular sciences.
Matthew C. Hill,
P. Ellinor,
K. Margulies,
2023,
Cell reports.
M. Kassem,
S. Johnsen,
W. Xie,
2017,
Nucleic acids research.
R. Simon,
M. Dobbelstein,
H. Will,
2016,
EMBO reports.
E. Nevedomskaya,
B. Haendler,
D. Mumberg,
2020,
Molecular oncology.
Clara D. Christ,
E. Nevedomskaya,
H. Briem,
2021,
Cellular Oncology.
Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models
E. Nevedomskaya,
B. Haendler,
H. Steuber,
2019,
International journal of cancer.
E. Nevedomskaya,
B. Haendler,
Simon J. Baumgart,
2018,
International journal of molecular sciences.
S. Knapp,
Roberto Tirado-Magallanes,
E. Hesse,
2016,
Nucleic acids research.
Clara D. Christ,
E. Nevedomskaya,
H. Briem,
2021,
Cellular Oncology.
G. Sauter,
R. Simon,
H. Huland,
2021,
Cancer Gene Therapy.
V. Ellenrieder,
M. Subramaniam,
J. Hawse,
2017,
Cancer research.
J. Karlsson,
A. Schlicker,
C. H. Nielsen,
2021,
Clinical Cancer Research.
M. Kassem,
S. Johnsen,
W. Xie,
2017
.
S. Bonn,
A. Mansouri,
M. Hennion,
2017,
Genome Biology.
Céline Hernandez,
D. Thieffry,
Morgane Thomas-Chollier,
2016,
Stem cells.
A. Schlicker,
P. Lienau,
B. Haendler,
2019,
Molecular Cancer Therapeutics.
R. Simon,
M. Dobbelstein,
H. Will,
2018,
EMBO reports.
S. Hayat,
C. Stegmann,
Yang Xu,
2021,
bioRxiv.
B. Haendler,
E. Corey,
O. Politz,
2024,
Molecular oncology.
A. Schlicker,
B. Haendler,
Christine Ellingsen,
2021
.